Lixuan Wei Selected Research

Lixuan Wei Research Topics

Disease

12	Neoplasms (Cancer) 02/2023 - 11/2015
3	Breast Neoplasms (Breast Cancer) 01/2023 - 01/2021
3	Alcoholism (Alcohol Abuse) 01/2022 - 01/2021
3	Lung Neoplasms (Lung Cancer) 01/2016 - 01/2014
2	Prostatic Neoplasms (Prostate Cancer) 01/2022 - 01/2022
2	Esophageal Squamous Cell Carcinoma 01/2018 - 11/2017
2	Neoplasm Metastasis (Metastasis) 11/2017 - 01/2017
2	Carcinogenesis 01/2016 - 10/2015
1	Abdominal Pain (Pain, Abdominal) 12/2023
1	Dizziness (Lightheadedness) 12/2023
1	Fatigue 12/2023
1	Primary Headache Disorders 12/2023
1	Mood Disorders (Mood Disorder) 11/2022
1	Osteoporosis 11/2022
1	Immune System Diseases (Immune Disorders) 11/2022
1	COVID-19 11/2022
1	Major Depressive Disorder (Major Depressive Disorders) 01/2021
1	Neuroinflammatory Diseases 01/2021
1	Genetic Predisposition to Disease (Genetic Predisposition) 01/2018
1	Carcinoma (Carcinomatosis) 01/2017
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2016
1	Fibrosarcoma 10/2015
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2014
1	B-Cell Lymphoma (Lymphoma, B Cell) 07/2013
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 07/2013
1	Lipoma (Lipomata) 07/2013

Drug/Important Bio-Agent (IBA)

6	Biomarkers (Surrogate Marker)IBA 02/2023 - 11/2015
3	Proteins (Proteins, Gene)FDA Link 11/2017 - 07/2013
2	GlucocorticoidsIBA 11/2022 - 11/2022
2	Acamprosate (Campral)FDA Link 01/2022 - 01/2021
2	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 11/2017
2	Messenger RNA (mRNA)IBA 11/2017 - 01/2017
1	Estrogen ReceptorsIBA 01/2023
1	enzalutamideIBA 01/2023
1	Circulating Tumor DNAIBA 01/2023
1	ChromatinIBA 01/2023
1	RAD140IBA 01/2023
1	Therapeutic UsesIBA 01/2023
1	Androgen Receptors (Androgen Receptor)IBA 01/2023
1	Antiviral Agents (Antivirals)IBA 11/2022
1	Poly Adenosine Diphosphate RiboseIBA 01/2022
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2022
1	fibroblast growth factor 21IBA 01/2022
1	CatecholaminesIBA 01/2022
1	abirateroneIBA 01/2022
1	Tryptophan (L-Tryptophan)FDA Link 01/2021
1	Ethanol (Ethyl Alcohol)IBA 01/2021
1	KynurenineIBA 01/2021
1	Trastuzumab (Herceptin)FDA Link 01/2021
1	Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA 01/2021
1	Serotonin (5 Hydroxytryptamine)IBA 01/2021
1	Alcohol Dehydrogenase (Alcohol Dehydrogenase (NAD+))IBA 01/2018
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 01/2017
1	ZincIBA 01/2017
1	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 01/2017
1	Mitogen-Activated Protein Kinase 1 (p42 MAP Kinase)IBA 01/2017
1	Matrix Metalloproteinases (MMPs)IBA 01/2017
1	P-2 (P 2)IBA 10/2016
1	ORALIT (ORS)IBA 01/2016
1	Long Noncoding RNAIBA 01/2016
1	Untranslated RNA (Noncoding RNA)IBA 01/2016
1	Caspase 3 (Caspase-3)IBA 01/2016
1	LuciferasesIBA 01/2016
1	MicroRNAs (MicroRNA)IBA 10/2015
1	PlatinumIBA 01/2014

Therapy/Procedure

3	Therapeutics 01/2023 - 01/2021
3	Drug Therapy (Chemotherapy) 11/2022 - 01/2014
1	Chinese Traditional Medicine (Traditional Chinese Medicine) 12/2023
1	Precision Medicine 02/2023
1	Complementary Therapies (Alternative Medicine) 01/2022
1	Castration 01/2022
1	Subcutaneous Injections 10/2015